title: Continuous ambulatory peritoneal dialysis, protective against developing dialysis-associated amyloid?
authors.forename: C
authors.initials: C
authors.lastname: Tielemans
authors.forename: M
authors.initials: M
authors.lastname: Dratwa
authors.forename: P
authors.initials: P
authors.lastname: Bergmann
authors.forename: M
authors.initials: M
authors.lastname: Goldman
authors.forename: B
authors.initials: B
authors.lastname: Flamion
authors.forename: F
authors.initials: F
authors.lastname: Collart
authors.forename: R
authors.initials: R
authors.lastname: Wens
mesh_terms: D000686:Amyloidosis / Q000209:etiology / Q000517:prevention & control*; D006801:Humans; D007668:Kidney / Q000378:metabolism / Q000503:physiopathology; D010531:Peritoneal Dialysis, Continuous Ambulatory; D001613:beta 2-Microglobulin / Q000032:analysis
chemical_list: D001613:beta 2-Microglobulin